Author: Jessica.F

Hodges, Alastair J. published the artcileIntramolecular nitrone dipolar cycloadditions: control of regioselectivity and synthesis of naturally-occurring spirocyclic alkaloids, HPLC of Formula: 69361-41-7, the publication is Organic & Biomolecular Chemistry (2012), 10(45), 8963-8974, database is CAplus and MEDLINE.

The intramol. nitrone dipolar cycloaddition of in situ-generated nitrones such as compound I has been used for the synthesis of cyclic isoxazolidines II and III. The regioselectivity of the intramol. cycloaddition depends on the nature of the terminal substituent on the dipolarophile. The influence of the substituent on the regioselectivity of the cycloaddition has been examined using several model systems and two methods of nitrone formation. These studies demonstrated that the cyano-substituent plays a special role in favoring the formation of the 6,6,5-ring fused adduct II under thermodynamically controlled conditions. The utility of the cyclo-adduct IV (BOM = CH₂OCH₂Ph; see Scheme 12) as a precursor for the naturally occurring histrionicotoxins is illustrated by the synthesis of three “unsym.” (i.e. with each side chain bearing different functional groups) members of the histrionicotoxin family HTX-259A, HTX-285C and HTX-285E [V; R = CH:CH₂, CH₂CH₂CH:CH₂, and CH:CHCH:CH-(Z), resp.].

Organic & Biomolecular Chemistry published new progress about 69361-41-7. 69361-41-7 belongs to bromides-buliding-blocks, auxiliary class PROTAC Linker,Aliphatic Linker, name is (4-Bromobut-1-yn-1-yl)trimethylsilane, and the molecular formula is C7H13BrSi, HPLC of Formula: 69361-41-7.

Referemce:
https://en.wikipedia.org/wiki/Bromide,
bromide – Wiktionary

Walter, Isabell published the artcileStructure-Activity Relationship and Mode-of-Action Studies Highlight 1-(4-Biphenylylmethyl)-1H-imidazole-Derived Small Molecules as Potent CYP121 Inhibitors, COA of Formula: C7H5Br2F, the publication is ChemMedChem (2021), 16(18), 2786-2801, database is CAplus and MEDLINE.

CYP121 of Mycobacterium tuberculosis (Mtb) is an essential target for the development of novel potent drugs against tuberculosis (TB). Besides known antifungal azoles, further compounds of the azole class were recently identified as CYP121 inhibitors with antimycobacterial activity. Herein, we report the screening of a similarity-oriented library based on the former hit compound, the evaluation of affinity toward CYP121, and activity against M. bovis BCG. The results enabled a comprehensive SAR study, which was extended through the synthesis of promising compounds and led to the identification of favorable features for affinity and/or activity and hit compounds with 2.7-fold improved potency. Mode of action studies show that the hit compounds inhibit substrate conversion and highlighted CYP121 as the main antimycobacterial target of our compounds Exemplified complex crystal structures of CYP121 with three inhibitors reveal a common binding site. Engaging in both hydrophobic interactions as well as hydrogen bonding to the sixth iron ligand, our compounds block a solvent channel leading to the active site heme. Addnl., we report the first CYP inhibitors that are able to reduce the intracellular replication of M. bovis BCG in macrophages, emphasizing their potential as future drug candidates against TB.

ChemMedChem published new progress about 76283-09-5. 76283-09-5 belongs to bromides-buliding-blocks, auxiliary class Fluoride,Bromide,Benzyl bromide,Benzene, name is 4-Bromo-1-(bromomethyl)-2-fluorobenzene, and the molecular formula is C8H8O3, COA of Formula: C7H5Br2F.

Referemce:
https://en.wikipedia.org/wiki/Bromide,
bromide – Wiktionary

Lv, Xin-Yang published the artcileDihydroquinazolinones as adaptative C(sp³) handles in arylations and alkylations via dual catalytic C-C bond-functionalization, SDS of cas: 143-15-7, the publication is Nature Communications (2022), 13(1), 2394, database is CAplus and MEDLINE.

C-C bond forming cross-couplings are convenient technologies for the construction of functional mols. Consequently, there is continual interest in approaches that can render traditionally inert functionality as cross-coupling partners, included in this are ketones which are widely-available commodity chems. and easy to install synthetic handles. Herein, a dual catalytic strategy that utilizes dihydroquinazolinones derived from ketone congeners as adaptative one-electron handles for forging C(sp³) architectures via α C-C cleavage with aryl and alkyl bromides is reported. This approach is achieved by combining the flexibility and modularity of nickel catalysis with the propensity of photoredox events for generating open-shell reaction intermediates. This method is distinguished by its wide scope and broad application profile–including chem. diversification of advanced intermediates–, providing a catalytic technique complementary to existing C(sp³) cross-coupling reactions that operates within the C-C bond-functionalization arena.

Nature Communications published new progress about 143-15-7. 143-15-7 belongs to bromides-buliding-blocks, auxiliary class Bromide,Aliphatic hydrocarbon chain, name is 1-Bromododecane, and the molecular formula is C12H25Br, SDS of cas: 143-15-7.

Referemce:
https://en.wikipedia.org/wiki/Bromide,
bromide – Wiktionary

Rook, Jerri M. published the artcileDiverse Effects on M₁ Signaling and Adverse Effect Liability within a Series of M₁ Ago-PAMs, Application In Synthesis of 76283-09-5, the publication is ACS Chemical Neuroscience (2017), 8(4), 866-883, database is CAplus and MEDLINE.

Both historical clin. and recent preclin. data suggest that the M1 muscarinic acetylcholine receptor is an exciting target for the treatment of Alzheimer’s disease and the cognitive and neg. symptom clusters in schizophrenia; however, early drug discovery efforts targeting the orthosteric binding site have failed to afford selective M1 activation. Efforts then shifted to focus on selective activation of M1 via either allosteric agonists or pos. allosteric modulators (PAMs). While M1 PAMs have robust efficacy in rodent models, some chemotypes can induce cholinergic adverse effects (AEs) that could limit their clin. utility. Here, the authors report studies aimed at understanding the subtle structural and pharmacol. nuances that differentiate efficacy from adverse effect liability within an indole-based series of M1 ago-PAMs. The authors’ data demonstrate that closely related M1 PAMs can display striking differences in their in vivo activities, and especially their propensities to induce adverse effects. The authors report the discovery of a novel PAM in this series that is devoid of observable adverse effect liability. Interestingly, the mol. pharmacol. profile of this novel PAM is similar to that of a representative M1 PAM that induces severe AEs. For instance, both compounds are potent ago-PAMs that demonstrate significant interaction with the orthosteric site (either bi-topic or neg. cooperativity). However, there are subtle differences in efficacies of the compounds at potentiating M1 responses, agonist potencies, and abilities to induce receptor internalization. While these differences may contribute to the differential in vivo profiles of these compounds, the in vitro differences are relatively subtle and highlight the complexities of allosteric modulators and the need to focus on in vivo phenotypic screening to identify safe and effective M1 PAMs.

ACS Chemical Neuroscience published new progress about 76283-09-5. 76283-09-5 belongs to bromides-buliding-blocks, auxiliary class Fluoride,Bromide,Benzyl bromide,Benzene, name is 4-Bromo-1-(bromomethyl)-2-fluorobenzene, and the molecular formula is C7H5Br2F, Application In Synthesis of 76283-09-5.

Referemce:
https://en.wikipedia.org/wiki/Bromide,
bromide – Wiktionary

Abadleh, Mohammed M. published the artcileThiophene ring-opening reactions. Direct access to the synthesis of 1,3,4-thiadiazoline-(condenced) pyridone hybrids, SDS of cas: 52431-30-8, the publication is Tetrahedron (2021), 131957, database is CAplus.

The reaction of N’-(aryl)benzothiohydrazides with 2-chloro-7-cyclopropyl-3-nitro-4-oxothieno[2,3-b]pyridine-5-carboxylic ester/acid in the presence of triethylamine furnished, upon addition of iodomethane, the resp. 1,3,4-thiadiazoline-(6-methylthio-4-oxopyridine) hybrids. Interestingly, the reaction of thiohydrazides with 4-oxothieno[2,3-b]pyridines incorporating N1-(2′-halogeno-5′-nitrophenyl) entities generated 1,3-thiazoline ring embedded in the resulting [fused]-tricyclic products. Similarly, the N1-(2′-chloropyridin-3′-yl) analog produced the resp. thiazolo[3,2-a: 5,6-b’]dipyridine-thiadiazoline hybrid. Monocyclic 2-chloro-3-nitrothiophenes in their reaction with benzothiohydrazide formed notable thiophene ring-opening products. This behavior is verified by quantum mech. calculations A proposed mechanistic pathway for this new reaction involving preferential predominance of thiophene ring-opening over Smiles rearrangement is presented.

Tetrahedron published new progress about 52431-30-8. 52431-30-8 belongs to bromides-buliding-blocks, auxiliary class Liquid Crystal &OLED Materials, name is 2,5-Dibromo-3,4-dinitrothiophene, and the molecular formula is C4Br2N2O4S, SDS of cas: 52431-30-8.

Referemce:
https://en.wikipedia.org/wiki/Bromide,
bromide – Wiktionary

Dankwardt, Sharon M. published the artcileAmino acid derived sulfonamide hydroxamates as inhibitors of procollagen C-Proteinase. Part 2: Solid-Phase optimization of side chains, Name: 4-Bromo-1-(bromomethyl)-2-fluorobenzene, the publication is Bioorganic & Medicinal Chemistry Letters (2002), 12(8), 1233-1235, database is CAplus and MEDLINE.

Optimization of the amino acid side chain and the N-alkyl group of the sulfonamide of amino acid derived sulfonamide hydroxamates is discussed. The solid-phase synthesis of these potent inhibitors (e.g., I) of procollagen C-proteinase (PCP) is presented. In addition, novel carboxylic acid sulfonamides were discovered to be PCP inhibitors.

Bioorganic & Medicinal Chemistry Letters published new progress about 76283-09-5. 76283-09-5 belongs to bromides-buliding-blocks, auxiliary class Fluoride,Bromide,Benzyl bromide,Benzene, name is 4-Bromo-1-(bromomethyl)-2-fluorobenzene, and the molecular formula is C7H5Br2F, Name: 4-Bromo-1-(bromomethyl)-2-fluorobenzene.

Referemce:
https://en.wikipedia.org/wiki/Bromide,
bromide – Wiktionary